The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
FDA has a drug shortage database which includes reasons for and updates on drug shortages. Today the…
An updated draft of USP Chapter 797 was released today. Updated Chapter 797 Posted for Public Comment: Separate Requirements…
The second year of the Quality Payment Program (QPP) authorized by the Medicare Access and…
12/01/24: Research Grant Cycle
Learn more
06/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 30, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Learn More and Register
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Bottom line Recent class action settlement gives all out-of-network (“ONET”) physicians important – and often overlooked –…
The essential tools and pearls for a successful allergy practice by those who have done…
July 2021 marks an almost 18 month journey through COVID. We have witnessed and personally…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
Building off the success of our radically re-designed Chicago Annual Meeting, we look forward to welcoming you to Philadelphia at the Loews Hotel on September 14—16, 2018. Your AAOA leadership has folded the Annual Meeting into your member dues value…
By Cecelia Damask, DO, Director of Educational Programs Due to popular demand, the AAOA is excited to announce that this year’s Advanced Course will be returning to beautiful, picturesque Vail Colorado. Vail is scenic, has beautiful weather, and of course is…
AAOA had participated in surveys for the American Medical Association’s (AMA) Relative Value Update Committee (RUC) for services commonly billed by members, including those for percutaneous allergy skin tests and nasal sinus endoscopy. In the proposed Physician Fee Schedule rule…
The Centers for Medicare and Medicaid Services (CMS) released a proposed rule outlining the requirements for Year 2 of the Quality Payment Program (QPP), including those requirements providers will have to meet to succeed in either the Merit-Based Incentive Payment…
By Cecelia Damask, DO, Director of Educational Programs I want to personally invite you this September, to join me in Chicago, where culture meets content at the redesigned AAOA Annual Meeting featuring the food, art, and architecture of Chicago, thoughtfully blended…
Strategies & Tactics to Improve Efficiencies for Better Patient Care In response to member feedback, we have expanded on continuing education content to include a full day of content on the business of medicine. When asked what keeps you up at…
The AAOA Education Committee is pleased to announce that, in addition to updating the format and educational venue for the Annual meeting, there will be a revision of the Basic Principles of Allergy workshop. The Basic Principles of Allergy program will emerge as ReCAP, which stands for Review of Core…
In an effort to maximize educational value, content, and time, the AAOA Education Committee has developed a unique learning experience for our 2017 Annual Meeting Attendees. Building on the “outside the classroom” concept to improve learning and networking and build…
Offering Winning Strategies for Your Practice By Cecelia Damask, DO, Director of Educational Programs, and Matthew Ryan, MD, Coordinator of Education This September, join us in Chicago, where culture meets content at the redesigned AAOA Annual Meeting featuring the food, art,…
There seem to be more and more medications available for allergy treatment that you can now purchase over the counter. The FDA has allowed some previously "prescription-only" drugs available directly to the consumer without a prescription which adds even more…
